首页 › 基金 › TOWERVIEW LLC › ALMS
TOWERVIEW LLC 对 ALMS 的持仓历史
ALUMIS INC · 医疗保健
TOWERVIEW LLC 在 Q3 2026 的 13F 申报中披露持有 ALMS(ALUMIS INC)277,500 股,市值约 US$2.1M,约占其申报组合的 1.49%,在其申报持仓中市值排名第 9 位。 TOWERVIEW LLC 最近 10 个申报季度中有 10 个季度披露了 ALMS 持仓,最早可追溯至 Q2 2024。
最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR
TOWERVIEW LLC 对 ALMS 的持仓演变
TOWERVIEW LLC 于 Q2 2024 首次披露 ALMS 持仓:310,000 股(约 US$4.1M)。 该持仓在 Q2 2026 达到峰值 222,294 股,市值约 US$6.3M。 在 10 次申报中,TOWERVIEW LLC 5 次增持、1 次减持、3 次保持不变。 最近一期申报(Q3 2026)显示持股 277,500 股、市值约 US$2.1M,环比增持 55,206 股。。 持仓曾出现大幅变动:Q1 2026 减持约 55% (随后一个季度股价上涨 28%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q2 2024 | 310.00K | $4.12M | 新进 |
| Q3 2024 | 380.00K | $4.06M | 增持 |
| Q4 2024 | 415.00K | $3.26M | 增持 |
| Q1 2025 | 430.00K | $2.64M | 增持 |
| Q2 2025 | 495.00K | $1.49M | 增持 |
| Q3 2025 | 495.00K | $1.98M | 持有 |
| Q4 2025 | 495.00K | $4.83M | 持有 |
| Q1 2026 | 222.29K | $4.90M | 减持 |
| Q2 2026 | 222.29K | $6.26M | 持有 |
| Q3 2026 | 277.50K | $2.05M | 增持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 ALMS 与 13F 数据
ALMS(ALUMIS INC)属于医疗保健行业。我们追踪的基金中还有 72 只申报持有 ALMS,申报仓位最大的包括:AyurMaya Capital Management Company, LP (US$426.0M), Deep Track Capital, LP (US$178.6M), Samsara BioCapital, LLC (US$178.6M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 ALMS 的基金
- AyurMaya Capital Management Company, LP 15.14M 股 · $426.03M · Q2 2026
- Deep Track Capital, LP 6.35M 股 · $178.65M · Q2 2026
- Samsara BioCapital, LLC 6.35M 股 · $178.55M · Q2 2026
- Foresite Capital Management V, LLC 5.90M 股 · $165.94M · Q2 2026
- venBio Partners LLC 4.53M 股 · $127.43M · Q2 2026
- Foresite Capital Management VI LLC 4.25M 股 · $119.53M · Q2 2026
- Nextech Invest Ltd. 3.54M 股 · $99.64M · Q2 2026
- Cormorant Asset Management, LP 3.29M 股 · $92.46M · Q2 2026
- Saturn V Capital Management LP 2.92M 股 · $82.04M · Q2 2026
- Octagon Capital Advisors LP 2.83M 股 · $79.66M · Q2 2026
- MPM BioImpact LLC 2.02M 股 · $56.82M · Q2 2026
- BAKER BROS. ADVISORS LP 2.01M 股 · $56.63M · Q2 2026
更多关于 TOWERVIEW LLC
常见问题
How long has TOWERVIEW LLC held ALMS?
TOWERVIEW LLC has disclosed ALMS holdings in 10 of the last 10 reported quarters, going back to Q2 2024.
What is TOWERVIEW LLC's current position in ALMS?
As of Q3 2026, TOWERVIEW LLC holds 277.50K shares of ALMS (ALUMIS INC), valued at $2.05M, representing 1.49% of its reported portfolio and ranking #9.
Has TOWERVIEW LLC been buying or selling ALMS?
In the latest 13F filing (Q3 2026), TOWERVIEW LLC increased its position in ALMS. The position peaked in Q2 2026 at 222.29K shares.
Which other funds hold ALMS?
Other major institutional holders of ALMS include AyurMaya Capital Management Company, LP, Deep Track Capital, LP, Samsara BioCapital, LLC, among 72 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.